SCOPE 2023: Small Biopharma Clinical Development

Education and equitable access are key to unlocking its full potential in the present and future.

Increased use of fentanyl underscores immediate need for better testing methods.

Findings suggests implementation could save time and money, but needs to be evaluated carefully.

The immense volume of available chemical compounds creates a significant challenge in the drug discovery process.

AI could present an innovative path forward in reshaping the landscape of global health strategies.

There is an expanding array of potential antibody-based treatment options, such as bispecific or multispecific antibodies, that show promise in addressing conditions such as cancer, engineered antibody fragments, or even antibody-drug conjugates.